4,0
17. März 2011
Mitarbeiter (anonym)
Aktueller Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Great experience, good benefits and good pay.
Kontras
Must be contracted to get through. Currently no permanent positions opened and there won't be one in awhile due to the Roche merger, therefore no room for growth.